Experienced in Arthrogryposis Multiplex Congenita

Dr. Carla M. Grosmann

Neurology
200 University Ave E, 
Saint Paul, MN 
Experienced in Arthrogryposis Multiplex Congenita
200 University Ave E, 
Saint Paul, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Carla Grosmann is a Neurologist in Saint Paul, Minnesota. Dr. Grosmann is rated as an Experienced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita. Her top areas of expertise are Collagen VI-Related Myopathy, Horizontal Gaze Palsy with Progressive Scoliosis, Benign Autosomal Dominant Myopathy, and Limb-Girdle Muscular Dystrophy.

Her clinical research consists of co-authoring 13 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Arthrogryposis Multiplex Congenita.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MN
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

200 University Ave E, Saint Paul, MN 55101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Drug
Study Drug: Givinostat
Study Phase: Phase 3
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

13 Total Publications

Taking on the Titin: Muscle imaging as a diagnostic marker of biallelic TTN-related myopathy.
Taking on the Titin: Muscle imaging as a diagnostic marker of biallelic TTN-related myopathy.
Journal: Journal of neuromuscular diseases
Published: February 19, 2025
Similar Doctors
Experienced in Arthrogryposis Multiplex Congenita
Dr. Pitcha Chompoopong
Neurology
Experienced in Arthrogryposis Multiplex Congenita
Dr. Pitcha Chompoopong
Neurology

Fairview Express Care

2450 Riverside Ave, 
Minneapolis, MN 
 (6.9 miles away)
612-672-7422
Languages Spoken:
English, Thai
See accepted insurances
Accepting New Patients
Offers Telehealth

Pitcha Chompoopong is a Neurologist in Minneapolis, Minnesota. Dr. Chompoopong is rated as an Experienced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita. Her top areas of expertise are Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, Limb-Girdle Muscular Dystrophy, Nerve Decompression, and Tissue Biopsy. Dr. Chompoopong is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grosmann's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile